Pharmaceutical companies in India and World are in continuous effort on the development of vaccines for COVID-19 and its trials. India has put 5 candidates for Oxford’s COVID-19 vaccine trials in Pune. The world has crossed 24 million in the number of COVID-19 cases. India can overtake Brazil in the coming 2 weeks if the current pace is continued to be.
Here, all the latest developments on the COVID-19 vaccine in India.
- Five more volunteers have been inoculated with Oxford’s CPVID-19 vaccine in Pune city. This is a 2nd trial phase in the search for an antidote against coronavirus infection. Volunteers are in Bharti Vidyapeeth’s Medical College and Hospital in Pune city, a senior doctor said.
- Premas Biotech has said its vaccine candidates have shown positive test results inducing a neutralizing immune response in animal studies. This company is in talks with Indian regulations for conducting human trials as a next step, premise biotech said.
- Serum Institute of India, the world’s largest vaccine manufacturer by volume, selected the cities in India to conduct phase 2nd trials of Oxfords’ COVID-19 vaccine for 1600 candidates.
- As far as Sputnik-V vaccine is concerned, India and Russia are in communication. “Some initial information has been shared while some detailed information is awaited.”- Rajesh Bhushan, Secretary of the union health ministry .
- Covaxin, as one of three vaccine candidates against COVID-19, being developed in India, approved for Skin trials by Central Drugs Standard Council Organisation (CDSCO).
A total of 26 vaccine candidates are being developed, according to WHO.
On seeing the rapid increase of COVID-19 cases, in India, there is a need to focus on fatality rates in districts and rural areas in India. He further added proactive steps to refine and strengthen the approach and strategies relating to testing, contact tracing, surveillance, containment, home isolation, availability of ambulance, hospital beds, oxygen treatment protocols, etc.